Hematopoietic stem cell transplant (HSCT) patients are at risk for acute kidney disease and CKD, which confer excess morbidity and mortality in this patient population. A main cause of acute kidney injury (AKI) in stem cell recipients is prerenal azotemia, but acute tubular necrosis (ATN), obstruction, marrow transfusion toxicity, and hepatic sinusoidal obstruction syndrome also contribute. AKI is an important risk factor for death and CKD among HSCT survivors. CKD is a growing complication of HSCT as more patients are transplanted and survival improves. For most patients, the exact etiology of CKD is never identified, but graft vs host disease and thrombotic microangiopathy are important diagnoses to consider. Stem cell transplant patient survival on dialysis is generally poor, but kidney transplantation is a safe and reasonable option for HSCT recipients who progress to ESRD. (C) 2014 by the National Kidney Foundation, Inc. All rights reserved.
机构:
Tokyo Womens Med Univ, Dept Internal Med 4, Tokyo, Japan
Tokyo Metropolitan Fuchu Med & Welf Ctr, Dept Med, Fuchu, Tokyo, JapanTokyo Womens Med Univ, Dept Internal Med 4, Tokyo, Japan
机构:
Rutgers Robert Wood Johnson Med Sch, Dept Internal Med, New Brunswick, NJ USARutgers Robert Wood Johnson Med Sch, Dept Internal Med, New Brunswick, NJ USA
Sedhom, Ramy
Sedhom, Daniel
论文数: 0引用数: 0
h-index: 0
机构:
Rutgers Robert Wood Johnson Med Sch, Dept Internal Med, New Brunswick, NJ USARutgers Robert Wood Johnson Med Sch, Dept Internal Med, New Brunswick, NJ USA
Sedhom, Daniel
Jaimes, Edgar
论文数: 0引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Renal Serv, 1275 York Ave, New York, NY 10021 USA
Weill Cornell Med Coll, Div Renal, New York, NY USARutgers Robert Wood Johnson Med Sch, Dept Internal Med, New Brunswick, NJ USA